International BioIron Society

Podium Awards

2017

Michela Asperti, PhD
Podium 27
FERROPTOSIS: A NEW POTENTIAL THERAPEUTIC TARGET FOR AGGRESSIVE TUMORS. A PRELIMINARY STUDY ON HELA, HEPG2 AND RHABDOMYOSARCOMA CELL LINES

2017

Deborah Stefanova
Podium 20
HEPCIDIN MEDIATES HOST DEFENSE AGAINST GRAM-NEGATIVE PATHOGENS BY CONTROLLING NON-TRANSFERRIN-BOUND IRON

2017

Antonella Nai, PhD
Podium 33
TFR2: A NOVEL POTENTIAL THERAPEUTIC TARGET FOR β -THALASSEMIA

2017

Veena Sangkhae, PhD
Podium 39
EFFECTS OF MATERNAL IRON STATUS ON PLACENTAL IRON TRANSFER

2017

Anthony Grillo, PhD
Podium 52
RESTORED IRON TRANSPORT BY A SMALL MOLECULE PROMOTES GUT IRON ABSORPTION AND HEMOGLOBINIZATION IN MICE, RATS, AND ZEBRAFISH

2015

Susanna Canali
Podium 51
ACTIVIN B UTILIZES ACTIVIN TYPE II RECEPTORS, BMP TYPE I RECEPTORS, HEMOJUVELIN AND SMAD1/5/8 SELECTIVELY IN HEPATOCYTES TO PROMOTE HEPCIDIN INDUCTION BY INFLAMMATION IN MICE

2015

Milene Costa de Silva
Podium 19
IRON LEVELS DEFINE TWO POPULATIONS OF TUMOR ASSOCIATED MACROPHAGES

2015

Debora Stefanova
Podium 46
THE ROLE OF IRON AND HEPCIDIN IN YERSINIA ENTEROCOLITICA INFECTION

2015

Francesca Vinchi
Podium 42
HEME AND IRON CONTROL OF MACROPHAGE PLASTICITY IS PREVENTED BY THE HEME SCAVENGER HEMOPEXIN AND THE IRON CHELATOR DFO

2013

Brie Fuqua, University of California, Berkeley, CA, USA
Podium 24
SEVERE DEFECTS IN IRON METABOLISM IN MICE WITH DOUBLE KNOCKOUT OF THE MULTICOPPER FERROXIDASES HEPHAESTIN AND CERULOPLASMIN Brie Fuqua (Presenter), Deepak Darshan, David Frazer, Sarah Wilkins, Chris Vulpe and Gregory Anderson (University of California, Berkeley, CA, USA, and the Queensland Institute of Medical Research, Brisbane, Australia)

2013

Claire Mayeur, Massachusetts General Hospital, Boston, MA, USA
Podium 40
IN A MOUSE MODEL OF CHRONIC INFLMATION, LIVER-SPECIFIC DELETION OF ALK3 (A BMP TYPE I RECEPTOR) PREVENTS THE DEVELOENT OF ANEMIA OF INFLMATION Claire Mayeur, MD (Presenter), Andrea S. Steinbicker, MD (Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Muenster, Muenster, Germany), Starsha A. Kolodziej and Kenneth D. Bloch, MD

2013

Léon Kautz, University of California Los Angeles, Center for Iron Disorders, Los Angeles, CA, USA
Podium 30
THE ERYTHROID FACTOR ERYTHROFERRONE AND ITS ROLE IN IRON HOMEOSTASIS Léon Kautz, PhD (Presenter), Elizabeta Nemeth, PhD and Tomas Ganz, PhD, MD

2013

Sandro Altamura, Molecular Medicine Partnership Unit, Heidelberg, Germancy
Podium 7
IN VIVO DISRUPTION OF THE HEPCIDIN-FERROPORTIN REGULATORY CIRCUITRY CAUSES FATAL SYSTEMIC AND EXOCRINE PANCREATIC IRON OVERLOAD Sandro Altamura (Presenter), Hermann-Josef Groene (Deutsches Krebsforschungszentrum, Heidelberg), Regina Kessler (MMPU), Bruno Galy (European Molecular Biology Laboratory, Heidelberg), Matthias Hentze (MMPU, EMBL) and Martina Muckenthaler (MMPU)

2013

Raffaella Gozzelino, Instituto Gulbenkian de Ciência, Oeiras, Portugal
Podium 2
METABOLIC ADAPTATION TO TISSUE IRON OVERLOAD CONFERS TOLERANCE TO MALARIA Raffaella Gozzelino, PhD (Presenter), Bruno Bezerril Andrade (2), Rasmus Larsen (3), Nivea F. Luz (4), Liviu Vanoaica (5), Antonio Coutinho (3), Silvia Cardoso (3), Sofia Rebelo (3), Maura Poli (6), Manoel Barral-Netto (7), Deepak Darshan (5), Lukas Kühn (5) and Miguel P. Soares (3)

(2) Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

(3) Inflammation Laboratory, Instituto Gulbenkian de Ciência, Oeiras, Portugal

(4) Centro de Pesquisas Gonçalo Moniz, undação Oswaldo Cruz (FIOCRUZ), Salvador, Bahia, Brazil

(5) Ecole Polytechnique Fédérale de Lausanne (EPFL), Swiss Institute for Experimental Cancer Research (ISREC), Switzerland

(6) Dipartimento Materno Infantile e Tecnologie Biomediche, University of Brescia, Italy

(7) Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Bahia, Brazil